XDND:F:F-Xtrackers MSCI North America High Dividend Yield UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 49.985

Change

0.00 (0.00)%

Market Cap

USD 0.11B

Volume

19.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+1.60 (+0.28%)

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.45 (-0.86%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.07 (-0.44%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-2.60 (-1.10%)

USD 45.80B
0ZC:F Zscaler Inc

-1.10 (-0.49%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.37%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

-0.46 (-0.36%)

USD 24.77B

ETFs Containing XDND:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.97% 28% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.97% 28% F 43% F
Trailing 12 Months  
Capital Gain 2.42% 43% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.42% 41% F 49% F
Trailing 5 Years  
Capital Gain 60.47% 57% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 60.47% 58% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain 12.00% 79% B- 70% C-
Dividend Return 12.00% 76% C+ 62% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.05% 60% D- 89% A-
Risk Adjusted Return 108.66% 96% N/A 95% A
Market Capitalization 0.11B 32% F 31% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.